The External Awards Program provides funding for investigator-initiated research projects in the form of one-year awards totaling approximately $100,000, paid out in three or more installments tied to progress reports throughout the term of the project. Clinical, pre-clinical, and early-stage projects can be funded through one of the program’s two submission tracks. This program typically does not fund large capital purchases, cannot fund overhead or institutional expenses, and will not fund the development of new focused ultrasound equipment. Exceptions to these guiding principles may be considered if the project addresses a gating factor in the near-term development of a reimbursable clinical application.
The program has two tracks. The Clinical Indication Track is geared primarily towards preclinical and first-in-human clinical studies.
The High-Risk Track is intended for early-stage, high-risk, proof-of-concept research.
Abstracts are accepted and reviewed on a rolling basis. Applicants will be notified within ten business days following submission of an abstract as to whether or not they have been invited to submit a full proposal.
The program has two tracks. The Clinical Indication Track is geared primarily towards preclinical and first-in-human clinical studies.
The High-Risk Track is intended for early-stage, high-risk, proof-of-concept research.
Abstracts are accepted and reviewed on a rolling basis. Applicants will be notified within ten business days following submission of an abstract as to whether or not they have been invited to submit a full proposal.